Amir L. Rifi studied biomedical research at the Vrije Universiteit Brussel and graduated magna cum laude in 2021. His master's thesis titled “Derivation of an adverse outcome pathway network for in vitro hepatotoxicity predictive testing” was performed in the In Vitro Toxicology and Dermato-Cosmetology (IVTD) department of the Vrije Universiteit Brussel.
In that same year, he enrolled as a Ph.D. candidate in the research groups of Translational Radiation Oncology and Palliative care (TROP) , and Biostatistics and Medical Informatics (BISI) under the supervision of Prof. Dr. Mark De Ridder and Prof. Dr. Kurt Barbé, with focus on the clinical translation of radiomics to support personalized cancer therapy.
